ANI Pharmaceuticals, Inc. ANIP
Set alert
72.00 USD -1.16 -1.59%
At close · Oct 30
72.00 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
71.90 Day range 73.54
69.58 52-week range 95.57
- YTD
- -8.79%
- 1 year
- -21.68%
- Open
- 73.27
- Prev close
- 73.16
- Mkt cap
- 1.65B
- Vol
- 286.90K
- Avg vol
- 387.84K
- EPS
- 4.62
- P/E
- 15.58
- Div yield
- 0.00%
More statistics
- Low
- 71.90
- High
- 73.54
- Forward P/E
- 7.14
- Beta
- 0.49
- Short ratio
- 8.21
- Inst. own
- 107.18%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 73.06
- 200-d avg
- 77.72
- 1y target
- 105.78
2Y chart
Events in this range
- Aug 8, 2025Earnings: 1.8; estimate 1.38; surprise 30.43%
- Nov 7, 2025Earnings: 2.04; estimate 1.74; surprise 17.24%
- Jan 16, 2026Rating: Guggenheim · Buy → Buy
- Feb 27, 2026Earnings: 2.33; estimate 1.99; surprise 17.09%
- May 8, 2026Earnings: 2.05; estimate 1.28; surprise 60.16%
- Jul 10, 2026Rating: Guggenheim · Buy → Buy
- Jul 17, 2026Rating: Canaccord Genuity · — → Hold
- Aug 7, 2026Earnings: 2.21; estimate 2.04; surprise 8.33%
- Aug 10, 2026Rating: Canaccord Genuity · Hold → Hold
- Aug 10, 2026Rating: Guggenheim · Buy → Buy
- Sep 23, 2026Rating: Oppenheimer · — → Perform
Signals (101)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 2 days ago |
| SMA: Bullish | Oct 29, 2026 | 3 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 19, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 13, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 12, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 21, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 20, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 31, 2026 | 3 months ago |
| SMA: Bearish | Jul 30, 2026 | 3 months ago |
| SMA: Bearish | Jul 30, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 30, 2026 | 3 months ago |
| SMA: Bullish | Jul 29, 2026 | 3 months ago |
| SMA: Bearish | Jul 17, 2026 | 3 months ago |
| SMA: Bearish | Jul 17, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 10, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 10, 2026 | 3 months ago |
| SMA: Bullish | Jun 25, 2026 | 4 months ago |
| SMA: Bearish | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 23, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 18, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 9, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
| SMA: Bearish | May 29, 2026 | 5 months ago |
| MACD: Sell Signal | May 28, 2026 | 5 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| MACD: Sell Signal | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 6 months ago |
| MACD: Buy Signal | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 28, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 18, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 12, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 10, 2026 | 7 months ago |
| SMA: Bearish | Feb 11, 2026 | 8 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Jan 29, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 27, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 14, 2026 | 9 months ago |
| SMA: Bearish | Jan 13, 2026 | 9 months ago |
| SMA: Bullish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 12, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Jan 9, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 9, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 8, 2026 | 9 months ago |
| SMA: Bullish | Jan 7, 2026 | 9 months ago |
| SMA: Bearish | Jan 6, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 2, 2026 | 10 months ago |
| MACD: Buy Signal | Nov 28, 2025 | 11 months ago |
| RSI: Oversold | Nov 14, 2025 | 11 months ago |
| SMA: Bearish | Nov 5, 2025 | 12 months ago |
| MACD: Sell Signal | Nov 5, 2025 | 12 months ago |
| MACD: Buy Signal | Nov 4, 2025 | 12 months ago |
| SMA: Bullish | Nov 3, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 30, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 20, 2025 | 1 year ago |
| SMA: Bullish | Oct 16, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 2, 2025 | 1 year ago |
| RSI: Overbought | Aug 8, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 6, 2025 | 1 year ago |
| SMA: Bullish | Aug 1, 2025 | 1 year ago |
| SMA: Bearish | Jul 31, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 29, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 11, 2025 | 1 year ago |
| SMA: Bullish | Jul 2, 2025 | 1 year ago |
| SMA: Bearish | Jul 1, 2025 | 1 year ago |
| SMA: Bullish | Jun 20, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 3, 2025 | 1 year ago |
| RSI: Oversold | May 22, 2025 | 1 year ago |
| RSI: Oversold | May 15, 2025 | 1 year ago |
| SMA: Bearish | May 9, 2025 | 1 year ago |
| MACD: Sell Signal | May 7, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 28, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 7, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 5, 2025 | 1 year ago |
| SMA: Bullish | Feb 28, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 13, 2025 | 1 year ago |
| SMA: Bullish | Jan 16, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 2, 2025 | 1 year ago |
Key statistics
- Market cap
- 1.66B
- Enterprise value
- 1.82B
- Trailing P/E
- 15.65
- Forward P/E
- 7.14
- PEG ratio
- 1.81
- Price / sales
- 1.70
- Price / book
- 2.59
- EPS (TTM)
- 4.62
- Beta
- 0.49
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 11.07%
- Revenue (TTM)
- 978.38M
- Revenue growth
- 25.90%
- Free cash flow
- 132.21M
- Total cash
- 376.96M
- Total debt
- 626.03M
- Return on equity
- 20.46%
- Shares outstanding
- 22.96M
- Short % of float
- 18.41%
- 50-day average
- 73.06
- 200-day average
- 77.72
Analyst view
Consensus: buy
Buy
Price target (mean) 105.78 +46.9% upside
Now 72.00
- Target (low)
- 85.00
- Target (mean)
- 105.78
- Target (high)
- 121.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
- Strong buy3
- Buy4
- Hold2
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 2.18.
Financials — quick view
ANIP Revenue — quarterly 266.04M
ANIP Net income — quarterly 24.71M
ANIP EPS — quarterly 1.09
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 2.18 | — | — | — |
| Aug 7, 2026 | Jun 30, 2026 | 2.04 | 2.21 | +0.17 | +8.33% |
| May 8, 2026 | Mar 31, 2026 | 1.28 | 2.05 | +0.77 | +60.16% |
| Feb 27, 2026 | Dec 31, 2025 | 1.99 | 2.33 | +0.34 | +17.09% |
| Nov 7, 2025 | Sep 30, 2025 | 1.74 | 2.04 | +0.30 | +17.24% |
| Aug 8, 2025 | Jun 30, 2025 | 1.38 | 1.80 | +0.42 | +30.43% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 23, 2026 | Oppenheimer | init | — | Perform |
| Aug 10, 2026 | Guggenheim | main | Buy | Buy |
| Aug 10, 2026 | Canaccord Genuity | main | Hold | Hold |
| Jul 17, 2026 | Canaccord Genuity | init | — | Hold |
| Jul 10, 2026 | Guggenheim | reit | Buy | Buy |
| Jan 16, 2026 | Guggenheim | main | Buy | Buy |
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- anipharmaceuticals.com
News
- ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET
- ANI Pharmaceuticals Launches Duloxetine Delayed-Release Capsules 20, 30 And 60 Mg, Generic Version Of Reference Listed Drug Cymbalta
- ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules
- ANI Pharmaceuticals (NASDAQ:ANIP) CEO Sells $388,206.00 in Stock
- Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?
- These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
- Head to Head Comparison: ANI Pharmaceuticals (NASDAQ:ANIP) and Talphera (NASDAQ:TLPH)
- ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting
- Implied Volatility Surging for ANI Pharmaceuticals Stock Options
- ANI Pharmaceuticals: Cortrophin's Q4 Test, With Generics Funding The Build
Your note
Sign in to keep a note on ANIP — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CAREY STEPHEN P. | Chief Financial Officer | Sale | Sep 28, 2026 | 168,993 |
| COOK MEREDITH | General Counsel | Sale | Oct 12, 2026 | 73,424 |
| DAVIS KRISTA | Officer | Sale | Mar 8, 2026 | 51,946 |
| GASSERT CHAD | Officer | Stock Award(Grant) | Feb 25, 2026 | 233,406 |
| GUTWERG ORI | Officer | Sale | Aug 9, 2026 | 75,534 |
| HAUGHEY THOMAS J | Director | Sale | Jun 7, 2026 | 38,878 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 12.89% | 2,958,646 | 213.92M | Jun 29, 2026 |
| Soleus Capital Management, L.P. | 3.78% | 867,760 | 62.74M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 3.65% | 838,224 | 60.61M | Jun 29, 2026 |
| State Street Corporation | 3.62% | 831,647 | 60.13M | Jun 29, 2026 |
| Tang Capital Management, LLC | 3.08% | 707,500 | 51.16M | Jun 29, 2026 |
| Dimensional Fund Advisors LP | 2.72% | 623,463 | 45.08M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.22% | 1,198,642 | 86.67M | Sep 29, 2026 |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 3.25% | 745,302 | 53.89M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.65% | 609,433 | 44.07M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.31% | 529,877 | 38.31M | Sep 29, 2026 |
| OBERWEIS FUNDS-Oberweis Micro-Cap Fund | 1.12% | 256,300 | 18.53M | Jun 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.98% | 224,189 | 16.21M | Jul 30, 2026 |